The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Role of cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC).
 
Pooja Ghatalia
No Relationships to Disclose
 
Elizabeth A. Handorf
Honoraria - NCCN/Pfizer
Research Funding - NCCN/Lilly (Inst); Pfizer (Inst); Pfizer (Inst)
 
Mengying Deng
No Relationships to Disclose
 
Matthew R. Zibelman
Honoraria - Pfizer
Consulting or Advisory Role - EMD Serono; Exelixis; Horizon Pharma; Janssen; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Horizon Pharma (Inst); Pfizer (Inst)
Other Relationship - Association of Community Cancer Centers (ACCC)
 
Philip Abbosh
Stock and Other Ownership Interests - Abyost PHarmaceuticals
Consulting or Advisory Role - ArTara Therapeutics
Research Funding - Adaptive Biotechnologies; natera
Patents, Royalties, Other Intellectual Property - Intravesical imidazolium compunds; urine biomarkers patent application
 
Fern Anari
No Relationships to Disclose
 
Richard E. Greenberg
No Relationships to Disclose
 
Rosalia Viterbo
No Relationships to Disclose
 
David Chen
Stock and Other Ownership Interests - Pfizer; Pfizer (I)
 
Marc C. Smaldone
No Relationships to Disclose
 
Alexander Kutikov
No Relationships to Disclose
 
Daniel M. Geynisman
Employment - 2nd.MD
Consulting or Advisory Role - AstraZeneca; Eisai; Exelixis; Merck; Myovant Sciences; Pfizer; Seattle Genetics/Astellas
Research Funding - Astellas Pharma (Inst); Calithera Biosciences (Inst); Genentech (Inst); Merck (Inst)
 
Robert Guy Uzzo
Consulting or Advisory Role - Amgen; Genentech/Roche; Pfizer; Urogen pharma
Speakers' Bureau - Janssen Oncology
Research Funding - Novartis